Halozyme Therapeutics Inc
NASDAQ:HALO
Income Statement
Earnings Waterfall
Halozyme Therapeutics Inc
Revenue
|
829.3m
USD
|
Cost of Revenue
|
-192.4m
USD
|
Gross Profit
|
636.9m
USD
|
Operating Expenses
|
-296.8m
USD
|
Operating Income
|
340.1m
USD
|
Other Expenses
|
-58.5m
USD
|
Net Income
|
281.6m
USD
|
Income Statement
Halozyme Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
55
N/A
|
55
+0%
|
59
+7%
|
58
-2%
|
75
+31%
|
82
+9%
|
107
+30%
|
113
+6%
|
135
+19%
|
159
+18%
|
149
-6%
|
160
+7%
|
147
-8%
|
134
-9%
|
134
+0%
|
166
+24%
|
317
+91%
|
318
+0%
|
319
+0%
|
281
-12%
|
152
-46%
|
178
+17%
|
182
+2%
|
202
+11%
|
196
-3%
|
164
-16%
|
181
+10%
|
200
+11%
|
268
+34%
|
331
+24%
|
413
+25%
|
463
+12%
|
443
-4%
|
472
+6%
|
488
+3%
|
581
+19%
|
660
+14%
|
705
+7%
|
774
+10%
|
781
+1%
|
829
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(6)
|
(11)
|
(16)
|
(20)
|
(23)
|
(24)
|
(26)
|
(27)
|
(29)
|
(31)
|
(31)
|
(34)
|
(33)
|
(33)
|
(32)
|
(32)
|
(31)
|
(27)
|
(20)
|
(12)
|
(10)
|
(12)
|
(13)
|
(34)
|
(46)
|
(47)
|
(51)
|
(34)
|
(43)
|
(56)
|
(73)
|
(86)
|
(81)
|
(79)
|
(90)
|
(119)
|
(139)
|
(159)
|
(175)
|
(182)
|
(192)
|
|
Gross Profit |
49
N/A
|
44
-10%
|
43
-2%
|
37
-13%
|
53
+41%
|
58
+11%
|
81
+39%
|
86
+6%
|
106
+23%
|
128
+21%
|
118
-8%
|
126
+7%
|
114
-10%
|
101
-11%
|
102
+1%
|
134
+32%
|
286
+112%
|
291
+2%
|
300
+3%
|
269
-10%
|
142
-47%
|
166
+17%
|
169
+2%
|
168
-1%
|
150
-11%
|
118
-22%
|
130
+10%
|
166
+28%
|
224
+35%
|
275
+23%
|
339
+23%
|
377
+11%
|
362
-4%
|
392
+8%
|
397
+1%
|
462
+16%
|
521
+13%
|
547
+5%
|
599
+10%
|
599
0%
|
637
+6%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(129)
|
(131)
|
(123)
|
(118)
|
(116)
|
(110)
|
(114)
|
(123)
|
(133)
|
(158)
|
(174)
|
(182)
|
(197)
|
(196)
|
(200)
|
(202)
|
(204)
|
(206)
|
(210)
|
(213)
|
(211)
|
(209)
|
(206)
|
(204)
|
(218)
|
(192)
|
(160)
|
(131)
|
(80)
|
(77)
|
(78)
|
(101)
|
(86)
|
(90)
|
(136)
|
(192)
|
(231)
|
(304)
|
(296)
|
(284)
|
(297)
|
|
Selling, General & Administrative |
(32)
|
(35)
|
(37)
|
(37)
|
(36)
|
(35)
|
(36)
|
(38)
|
(40)
|
(41)
|
(43)
|
(44)
|
(46)
|
(48)
|
(50)
|
(51)
|
(54)
|
(55)
|
(56)
|
(58)
|
(61)
|
(65)
|
(68)
|
(71)
|
(77)
|
(72)
|
(66)
|
(59)
|
(46)
|
(44)
|
(46)
|
(47)
|
(50)
|
(52)
|
(78)
|
(99)
|
(122)
|
(147)
|
(147)
|
(148)
|
(149)
|
|
Research & Development |
(97)
|
(96)
|
(87)
|
(81)
|
(80)
|
(75)
|
(78)
|
(85)
|
(93)
|
(117)
|
(131)
|
(137)
|
(151)
|
(148)
|
(150)
|
(151)
|
(151)
|
(152)
|
(154)
|
(155)
|
(150)
|
(144)
|
(137)
|
(132)
|
(141)
|
(120)
|
(95)
|
(72)
|
(34)
|
(33)
|
(32)
|
(33)
|
(36)
|
(39)
|
(46)
|
(54)
|
(67)
|
(73)
|
(77)
|
(78)
|
(76)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(39)
|
(43)
|
(61)
|
(67)
|
(58)
|
(71)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
0
|
0
|
(23)
|
(5)
|
0
|
0
|
|
Operating Income |
(80)
N/A
|
(87)
-8%
|
(80)
+8%
|
(80)
-1%
|
(63)
+22%
|
(52)
+18%
|
(33)
+37%
|
(37)
-13%
|
(28)
+25%
|
(30)
-8%
|
(56)
-87%
|
(55)
+1%
|
(83)
-51%
|
(95)
-14%
|
(98)
-4%
|
(68)
+31%
|
81
N/A
|
85
+5%
|
90
+6%
|
57
-37%
|
(69)
N/A
|
(43)
+38%
|
(37)
+14%
|
(36)
+3%
|
(68)
-90%
|
(74)
-9%
|
(30)
+59%
|
35
N/A
|
144
+317%
|
198
+37%
|
262
+32%
|
276
+5%
|
276
0%
|
302
+10%
|
262
-13%
|
270
+3%
|
289
+7%
|
243
-16%
|
303
+25%
|
315
+4%
|
340
+8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(11)
|
(15)
|
(19)
|
(20)
|
(20)
|
(20)
|
(19)
|
(18)
|
(16)
|
(13)
|
(11)
|
(8)
|
(6)
|
(4)
|
(5)
|
(6)
|
(10)
|
(13)
|
(15)
|
(14)
|
(12)
|
(9)
|
(6)
|
(6)
|
(9)
|
(14)
|
(16)
|
(16)
|
(14)
|
(6)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
(21)
|
0
|
(21)
|
(2)
|
(20)
|
(23)
|
(25)
|
0
|
0
|
(4)
|
(3)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
|
Pre-Tax Income |
(84)
N/A
|
(91)
-9%
|
(84)
+7%
|
(85)
-1%
|
(68)
+20%
|
(57)
+17%
|
(38)
+34%
|
(42)
-11%
|
(32)
+23%
|
(37)
-15%
|
(67)
-80%
|
(70)
-5%
|
(102)
-46%
|
(115)
-13%
|
(119)
-3%
|
(88)
+26%
|
62
N/A
|
67
+9%
|
75
+11%
|
44
-42%
|
(80)
N/A
|
(51)
+36%
|
(43)
+16%
|
(40)
+7%
|
(72)
-83%
|
(80)
-11%
|
(40)
+50%
|
22
N/A
|
129
+499%
|
164
+26%
|
229
+40%
|
267
+16%
|
249
-7%
|
295
+19%
|
233
-21%
|
233
0%
|
249
+7%
|
227
-9%
|
290
+28%
|
318
+10%
|
348
+10%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
2
|
2
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
142
|
154
|
140
|
133
|
(22)
|
(47)
|
(45)
|
(56)
|
(64)
|
(67)
|
|
Income from Continuing Operations |
(84)
|
(91)
|
(84)
|
(85)
|
(68)
|
(57)
|
(38)
|
(42)
|
(32)
|
(37)
|
(67)
|
(71)
|
(103)
|
(116)
|
(120)
|
(88)
|
63
|
68
|
76
|
46
|
(80)
|
(51)
|
(43)
|
(40)
|
(72)
|
(80)
|
(40)
|
22
|
129
|
163
|
229
|
409
|
403
|
435
|
366
|
211
|
202
|
182
|
234
|
254
|
282
|
|
Net Income (Common) |
(84)
N/A
|
(91)
-9%
|
(84)
+7%
|
(85)
-1%
|
(68)
+20%
|
(57)
+17%
|
(38)
+34%
|
(42)
-11%
|
(32)
+23%
|
(37)
-15%
|
(67)
-81%
|
(71)
-7%
|
(103)
-44%
|
(116)
-13%
|
(120)
-3%
|
(88)
+26%
|
63
N/A
|
68
+8%
|
76
+12%
|
46
-40%
|
(80)
N/A
|
(51)
+36%
|
(43)
+16%
|
(40)
+7%
|
(72)
-81%
|
(80)
-11%
|
(40)
+50%
|
22
N/A
|
129
+500%
|
163
+26%
|
229
+40%
|
409
+79%
|
403
-2%
|
435
+8%
|
366
-16%
|
211
-42%
|
202
-4%
|
182
-10%
|
234
+29%
|
254
+9%
|
282
+11%
|
|
EPS (Diluted) |
-0.73
N/A
|
-0.78
-7%
|
-0.67
+14%
|
-0.7
-4%
|
-0.56
+20%
|
-0.45
+20%
|
-0.3
+33%
|
-0.33
-10%
|
-0.25
+24%
|
-0.3
-20%
|
-0.53
-77%
|
-0.57
-8%
|
-0.81
-42%
|
-0.91
-12%
|
-0.89
+2%
|
-0.61
+31%
|
0.45
N/A
|
0.47
+4%
|
0.53
+13%
|
0.31
-42%
|
-0.56
N/A
|
-0.35
+38%
|
-0.29
+17%
|
-0.27
+7%
|
-0.5
-85%
|
-0.58
-16%
|
-0.28
+52%
|
0.16
N/A
|
0.91
+469%
|
1.09
+20%
|
1.56
+43%
|
2.79
+79%
|
2.74
-2%
|
3.07
+12%
|
2.57
-16%
|
1.51
-41%
|
1.44
-5%
|
1.3
-10%
|
1.75
+35%
|
1.89
+8%
|
2.1
+11%
|